With a revenue increase of 206.17% in the second quarter 2026, year on year to cumulative value of $188 million, Urogen Pharma Ltd 's revenue per employee grew on a trailing twelve months basis to $ 647,137, this marks a new company high.
Within the Healthcare sector Employees of 189 other companies have achieved higher revenue per employee. While Urogen Pharma Ltd 's total ranking has deteriorated compared to the previous quarter from 677 to 1680. Urogen Pharma Ltd has 291 employees.

What is Sales per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Revenue per Employee▼

None ▼

Revenue per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

URGN Revenue per Employee	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Revenue Change	206.17 %	155.07 %	54.03 %	9.91 %	9.46 %
Sales per Employee (TTM) $	647,137	479,471	373,299	327,691	319,261
URGN's Total Ranking	# 1680	# 677	# 1226	# 876	# 1347
Seq. Revenue Change	42.57 %	34.31 %	39.09 %	14.95 %	18.78 %

URGN Company Profile >> Back to URGN Efficiency Comparisons >> Compare URGN Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 112
Healthcare Sector	# 190
Overall Market	# 1680

Revenue per Employee Statistics
High	Average	Low
$ 647,137	$ 260,465	$ 28,034
(Jun 30 2026)		(Dec 31 2017)

Financial Statements
Urogen Pharma Ltd 's Revenue MRQ	$ 72 Millions	Visit URGN's Income Statement
Urogen Pharma Ltd 's Revenues TTM	$ 188 Millions	Visit URGN's aggregate revenue growth
What are URGN's Sales?		Visit URGN's Sales by Segment

Other Ratios
Urogen Pharma Ltd 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
URGN's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for URGN's Competitors
Revenue per Employee for URGN's Suppliers
Revenue per Employee for URGN's Customers

You may also want to know
URGN's Sales Growth Rates	URGN's Pe Price to earnings ratio	URGN's Receivables Turnover Ratio	URGN's Stock Quote
URGN's Net Income Growth Rates	URGN's Ps Price to Sales ratio	URGN's Sales per Employee	URGN's Asset Turnover Ratio
URGN's Net Margin	URGN's Pb Price to Book ratio	URGN's Financial Strength Ratios	URGN's Dividend Payout Ratio

Date modified: 2026-09-09T22:40:24+00:00

Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector	Revenue per Employee	Revenue 12 months ending Jun 30 2026	Number of Employees Jun 30 2026
Abbvie Inc	1,129,578.95	$ 64,386.000 Million	57,000
Akebia Therapeutics Inc	1,129,175.26	$ 219.060 Million	194
Siga Technologies Inc	1,095,079.92	$ 53.659 Million	49
Biomarin Pharmaceutical Inc	1,057,626.20	$ 3,406.614 Million	3,221
Hims and Hers Health Inc	1,055,894.35	$ 2,578.494 Million	2,442
Assembly Biosciences Inc	1,025,273.97	$ 74.845 Million	73
Sanara Medtech Inc	1,019,592.91	$ 110.116 Million	108
Ptc Therapeutics inc	1,017,915.24	$ 1,008.754 Million	991
Ani Pharmaceuticals Inc	1,008,638.14	$ 978.379 Million	970
Regeneron Pharmaceuticals Inc	1,008,092.15	$ 15,534.700 Million	15,410
Coya Therapeutics Inc	1,002,393.13	$ 8.019 Million	8
Meiragtx Holdings Plc	986,354.84	$ 397.501 Million	403
Evolus Inc	949,440.12	$ 317.113 Million	334
Arrowhead Pharmaceuticals Inc	941,624.47	$ 669.495 Million	711
Scilex Holding Company	929,647.06	$ 31.608 Million	34
Ardelyx inc	922,073.62	$ 450.894 Million	489
The Oncology Institute Inc	916,137.29	$ 587.244 Million	641
Pacira Biosciences inc	900,077.20	$ 746.164 Million	829
Fortress Biotech Inc	897,217.95	$ 69.983 Million	78
Alphatec Holdings Inc	892,420.59	$ 814.780 Million	913
Merck and Co Inc	887,586.67	$ 66,569.000 Million	75,000
Nektar Therapeutics	866,492.06	$ 54.589 Million	63
Carlisle Companies Incorporated	863,898.31	$ 5,097.000 Million	5,900
Verastem Inc	858,098.04	$ 87.526 Million	102
Emergent Biosolutions Inc	855,777.78	$ 770.200 Million	900
Bridgebio Pharma Inc	849,903.46	$ 713.069 Million	839
Pfizer Inc	849,280.00	$ 63,696.000 Million	75,000
Syndax Pharmaceuticals Inc	845,651.01	$ 252.004 Million	298
Xilio Therapeutics Inc	843,315.79	$ 64.092 Million	76
Axsome Therapeutics Inc	839,534.05	$ 776.569 Million	925

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.